Related Experiment Videos
[Sentinel lymphadenectomy in malignant melanoma]
H K Büchels1, D Bachter, H Vogt
1Funktionsbereich Plastische Chirurgie, Klinik für Allgemein- u. Viszeralchirurgie, Zentralklinikum Augsburg.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|September 17, 1998
Summary
Sentinel lymph node dissection (SLND) precisely stages melanoma by analyzing a few nodes, improving patient selection. While refined since 1992, its clinical utility remains under investigation.
Area of Science:
- Oncology
- Surgical Oncology
- Diagnostic Pathology
Context:
- Melanoma treatment has evolved significantly.
- Sentinel lymph node dissection (SLND) emerged as a key development.
- Its adoption increased as an alternative to elective lymph node dissection (ELND).
Purpose:
- To provide precise pathologic staging for melanoma patients.
- To differentiate patients with occult nodal disease from those with a tumor-free basin.
- To avoid unnecessary radical dissection in eligible patients.
Summary:
- SLND involves removing and analyzing a limited number of lymph nodes.
- It achieves a low false-negative rate (less than 2%).
- This method refines patient management by identifying nodal involvement accurately.
Impact:
- SLND enhances staging accuracy in melanoma.
- It potentially spares patients from extensive surgery.
- Further research is needed to confirm the long-term utility of SLND.